W. Keith Hoots

8.0k total citations
97 papers, 4.2k citations indexed

About

W. Keith Hoots is a scholar working on Hematology, Genetics and Hepatology. According to data from OpenAlex, W. Keith Hoots has authored 97 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 18 papers in Genetics and 9 papers in Hepatology. Recurrent topics in W. Keith Hoots's work include Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (23 papers) and Blood Coagulation and Thrombosis Mechanisms (16 papers). W. Keith Hoots is often cited by papers focused on Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (23 papers) and Blood Coagulation and Thrombosis Mechanisms (16 papers). W. Keith Hoots collaborates with scholars based in United States, Sweden and Canada. W. Keith Hoots's co-authors include Cheng‐Hock Toh, Bruce M. Ewenstein, Cindy Leissinger, Donna DiMichele, Diane J. Nugent, Philip M. Blatt, Georges‐Étienne Rivard, Elena Santagostino, Craig M. Kessler and S. W. PIPE and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

W. Keith Hoots

95 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Keith Hoots United States 34 2.5k 586 574 530 410 97 4.2k
Mark A. Popovsky United States 39 1.7k 0.7× 470 0.8× 640 1.1× 257 0.5× 222 0.5× 111 5.8k
Nancy Robitaille Canada 16 1.5k 0.6× 1.0k 1.7× 596 1.0× 245 0.5× 531 1.3× 57 3.8k
John Pasi United Kingdom 41 3.7k 1.5× 423 0.7× 837 1.5× 513 1.0× 238 0.6× 161 6.8k
Pearl Toy United States 33 806 0.3× 591 1.0× 405 0.7× 213 0.4× 210 0.5× 93 4.2k
Cindy Leissinger United States 28 1.9k 0.8× 266 0.5× 549 1.0× 233 0.4× 212 0.5× 103 2.6k
Anand Padmanabhan United States 26 1.5k 0.6× 278 0.5× 591 1.0× 243 0.5× 132 0.3× 70 3.9k
Patrizia Chiusolo Italy 33 2.0k 0.8× 327 0.6× 1.0k 1.8× 431 0.8× 63 0.2× 212 4.3k
W. Kreuz Germany 39 3.0k 1.2× 297 0.5× 1.7k 3.0× 217 0.4× 78 0.2× 137 4.7k
Massimo Morfini Italy 45 5.4k 2.1× 237 0.4× 1.3k 2.3× 156 0.3× 216 0.5× 199 6.1k
Rendrik F. Franco Brazil 27 1.2k 0.5× 301 0.5× 284 0.5× 265 0.5× 57 0.1× 63 2.1k

Countries citing papers authored by W. Keith Hoots

Since Specialization
Citations

This map shows the geographic impact of W. Keith Hoots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Keith Hoots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Keith Hoots more than expected).

Fields of papers citing papers by W. Keith Hoots

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Keith Hoots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Keith Hoots. The network helps show where W. Keith Hoots may publish in the future.

Co-authorship network of co-authors of W. Keith Hoots

This figure shows the co-authorship network connecting the top 25 collaborators of W. Keith Hoots. A scholar is included among the top collaborators of W. Keith Hoots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Keith Hoots. W. Keith Hoots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pusateri, Anthony E., et al.. (2018). The interagency strategic plan for research and development of blood products and related technologies for trauma care and emergency preparedness 2015-2020. American Journal of Disaster Medicine. 13(3). 181–194. 4 indexed citations
2.
Lauer, Michael S., James P. Kiley, Stephen Mockrin, et al.. (2015). National Heart, Lung, and Blood Institute (NHLBI) Strategic Visioning. Journal of the American College of Cardiology. 65(11). 1130–1133. 12 indexed citations
3.
Hoots, W. Keith & Susan B. Shurin. (2012). Future directions of sickle cell disease research: The NIH perspective. Pediatric Blood & Cancer. 59(2). 353–357. 22 indexed citations
4.
Hoots, W. Keith. (2010). The Registry and Surveillance in Hemoglobinopathies. American Journal of Preventive Medicine. 38(4). S510–S511. 8 indexed citations
5.
Astermark, Jan, Elena Santagostino, & W. Keith Hoots. (2010). Clinical issues in inhibitors. Haemophilia. 16(s5). 54–60. 41 indexed citations
6.
Valentino, Leonard A., Manuel Carção, Prasad Mathew, et al.. (2009). The application of bypassing‐agent prophylaxis in haemophilia A patients with inhibitors: a meeting report. Haemophilia. 15(4). 959–965. 11 indexed citations
7.
Hoots, W. Keith. (2008). Arthropathy in Inhibitor Patients: Differences in the Joint Status. Seminars in Hematology. 45(2 Suppl 1). S42–S49. 8 indexed citations
8.
Powner, David J. & W. Keith Hoots. (2008). Thrombocytosis in the NICU. Neurocritical Care. 8(3). 471–475. 7 indexed citations
9.
DiMichele, Donna, W. Keith Hoots, S. W. PIPE, Georges‐Étienne Rivard, & Elena Santagostino. (2007). International workshop on immune tolerance induction: consensus recommendations1. Haemophilia. 13(s1). 1–22. 222 indexed citations
10.
Leissinger, Cindy, Philip M. Blatt, W. Keith Hoots, & Bruce M. Ewenstein. (2007). Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. American Journal of Hematology. 83(2). 137–143. 247 indexed citations
11.
Hoots, W. Keith. (2006). Challenges in the Therapeutic Use of a “So-Called” Universal Hemostatic Agent: Recombinant Factor VIIa. Hematology. 2006(1). 426–431. 15 indexed citations
12.
Berntorp, Erik, Jan Astermark, V. Blanchette, et al.. (2006). Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia. 12(s6). 1–7. 82 indexed citations
13.
14.
Konkle, Barbara A., Liselotte S. Ebbesen, G. Auerswald, et al.. (2006). Secondary Prophylaxis with rFVIIa Improves Quality of Life of Hemophilia Patients with Inhibitors and Frequent Bleeds.. Blood. 108(11). 1028–1028. 2 indexed citations
15.
Lynn, Henry, Sharyne Donfield, Edward D. Gomperts, et al.. (2001). Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs. The Journal of Infectious Diseases. 183(4). 589–595. 102 indexed citations
16.
Taylor, Fletcher B., Cheng‐Hock Toh, W. Keith Hoots, Hideo Wada, & Marcel Levi. (2001). Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation* On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the ISTH. Thrombosis and Haemostasis. 86(11). 1327–1330. 34 indexed citations
17.
Hoots, W. Keith, et al.. (2001). The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety. Transfusion Medicine Reviews. 15(2B). 45–59. 9 indexed citations
18.
Hoots, W. Keith, Elizabeth M. Mahoney, Sharyne Donfield, et al.. (1998). Are There Clinical and Laboratory Predictors of 5-Year Mortality in HIV-Infected Children and Adolescents With Hemophilia?. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 18(4). 349–357. 10 indexed citations
19.
Hilgartner, Margaret W., Sharyne Donfield, Anne Willoughby, et al.. (1993). Hemophilia Growth and Development Study. Journal of Pediatric Hematology/Oncology. 15(2). 208–218. 104 indexed citations
20.
Hoots, W. Keith, G. R. Buchanan, Richard T. Parmley, et al.. (1991). Comprehensive care for patients with hemophilia: an expanded role in reducing risk for human immunodeficiency virus.. PubMed. 87(6). 73–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Popovsky Breakdown of academic impact, for papers by Nancy Robitaille Breakdown of academic impact, for papers by John Pasi Breakdown of academic impact, for papers by Pearl Toy Breakdown of academic impact, for papers by Cindy Leissinger Breakdown of academic impact, for papers by Anand Padmanabhan Breakdown of academic impact, for papers by Patrizia Chiusolo Breakdown of academic impact, for papers by W. Kreuz Breakdown of academic impact, for papers by Massimo Morfini Breakdown of academic impact, for papers by Rendrik F. Franco
Rankless by CCL
2026